Timo Vesikari
#125,459
Most Influential Person Now
Timo Vesikari's AcademicInfluence.com Rankings
Timo Vesikariphilosophy Degrees
Philosophy
#5867
World Rank
#8789
Historical Rank
Logic
#3075
World Rank
#4182
Historical Rank
Timo Vesikaribiology Degrees
Biology
#7904
World Rank
#10896
Historical Rank
Virology
#169
World Rank
#174
Historical Rank
Immunology
#431
World Rank
#448
Historical Rank
Download Badge
Philosophy Biology
Timo Vesikari's Degrees
- Doctorate Medicine University of Helsinki
- PhD Virology University of Helsinki
Why Is Timo Vesikari Influential?
(Suggest an Edit or Addition)Timo Vesikari's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. (2006) (1805)
- Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. (2006) (1615)
- Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. (2015) (914)
- Live attenuated versus inactivated influenza vaccine in infants and young children. (2007) (794)
- Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. (1990) (687)
- Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study (2007) (638)
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. (2016) (631)
- Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis (1995) (576)
- Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. (1997) (418)
- Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. (1995) (394)
- Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. (2012) (386)
- Burden of Rotavirus Disease in European Union Countries (2006) (367)
- PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE (1984) (336)
- Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. (1997) (317)
- Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. (1995) (312)
- Oil-in-water emulsion adjuvant with influenza vaccine in young children. (2011) (300)
- Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis (1997) (293)
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children (2011) (283)
- Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials (2013) (258)
- Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine (2009) (252)
- Human caliciviruses in acute gastroenteritis of young children in the community. (2000) (245)
- Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants (2004) (203)
- Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland (2013) (198)
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant (2009) (185)
- Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. (1968) (184)
- A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea (1997) (183)
- A six‐fold gradient in the incidence of type 1 diabetes at the eastern border of Finland (2005) (173)
- Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. (1985) (171)
- Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care (2006) (168)
- A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis (2004) (163)
- One-step quantitative RT-PCR for the detection of rotavirus in acute gastroenteritis. (2008) (153)
- Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. (1999) (149)
- Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. (2004) (141)
- IMMUNOGENICITY AND SAFETY OF LIVE ORAL ATTENUATED BOVINE ROTAVIRUS VACCINE STRAIN RIT 4237 IN ADULTS AND YOUNG CHILDREN (1983) (140)
- Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation (2005) (139)
- Efficacy, Immunogenicity, and Safety of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine at the End of Shelf Life (2007) (138)
- Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults. (2010) (136)
- MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. (2009) (133)
- Increased prevalence of coeliac disease in diabetes. (1984) (127)
- Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. (2011) (127)
- Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. (2006) (122)
- Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease. (1984) (116)
- Efficacy of high-titer live attenuated varicella vaccine in healthy young children. (1996) (114)
- Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features (1999) (113)
- A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. (1986) (113)
- A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine (2006) (110)
- Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older (2018) (103)
- Rotavirus vaccination: a concise review. (2012) (100)
- Mixed viral infections causing acute gastroenteritis in children in a waterborne outbreak (2010) (98)
- Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries). (2007) (94)
- RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe. (2009) (94)
- Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice (2013) (91)
- Rotavirus Types in Europe and Their Significance for Vaccination (2006) (89)
- European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Evidence-Based Recommendations for Rotavirus Vaccination in Europe (2008) (89)
- Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age. (1990) (89)
- Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine (2010) (88)
- Rotavirus vaccination in Europe: drivers and barriers. (2014) (88)
- Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials (2020) (88)
- Safety and Reactogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Routine Childhood Vaccines (2009) (87)
- A comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particles (2012) (86)
- A Randomized Double‐Blind, Placebo‐Controlled Trial of Dexamethasone and Racemic Epinephrine in the Treatment of Croup (1988) (86)
- A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles (2010) (85)
- Plasmids in Yersinia enterocolitica serotypes O:3 and O:9: correlation with epithelial cell adherence in vitro (1981) (84)
- A Prospective Study of Acute Diarrhoea in Finnish Children from Birth to 2 1/2 Years of Age (1991) (83)
- Increased Interleukin‐1 (IL‐1) Production from LPS‐Stimulated Peripheral Blood Monocytes in Children with Febrile Convulsions (1990) (78)
- Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study (2010) (78)
- Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland (2016) (78)
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls (2015) (77)
- Decline of mumps antibodies in Type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of Type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland (1993) (77)
- Prevalence of norovirus GII‐4 antibodies in Finnish children (2011) (76)
- Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. (2006) (76)
- IL‐10 gene polymorphism at −1082 A/G is associated with severe rhinovirus bronchiolitis in infants (2008) (74)
- Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillusstrain GG (1998) (74)
- Clinical experience with a hypotonic oral rehydration solution in acute diarrhoea (1993) (74)
- A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. (2005) (73)
- Detection of Norwalk virus or Norwalk-like virus infections in Finnish infants and young children. (1994) (73)
- Bordetella pertussis Infection Is Common in Nonvaccinated Infants Admitted for Bronchiolitis (2010) (72)
- High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children. (2014) (72)
- Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles-mumps-rubella-varicella vaccine during the second year of life: An open, randomized controlled trial. (2011) (72)
- Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. (2003) (71)
- Evaluation of the M37 human rotavirus vaccine in 2‐ to 6‐month‐old infants (1991) (70)
- Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009–2010 (2011) (70)
- Rotavirus, adenovirus, and non-viral enteropathogens in diarrhoea. (1981) (68)
- Detection of human coronaviruses in children with acute gastroenteritis (2010) (67)
- Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. (2009) (66)
- Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. (1992) (66)
- Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. (2018) (66)
- Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children. (2011) (64)
- Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children. (2010) (64)
- Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. (1999) (64)
- Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. (2013) (64)
- Mannan binding lectin deficiency and concomitant immunodefects (1998) (63)
- Aichi virus infection in children with acute gastroenteritis in Finland (2009) (63)
- Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction. (1969) (63)
- Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe. (2010) (61)
- Milk Versus No Milk in Rapid Refeeding After Acute Gastroenteritis (1986) (60)
- Isolation of attenuated rubella-vaccine virus from human products of conception and uterine cervix. (1972) (60)
- Humoral and cell‐mediated immune responses in humans to the NSP4 enterotoxin of rotavirus (1999) (60)
- Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence (2010) (60)
- Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis. (1999) (59)
- Human astrovirus‐associated gastroenteritis in children under 2 years of age followed prospectively during a rotavirus vaccine trial (1999) (59)
- Viral Etiology and Incidence of Acute Gastroenteritis in Young Children Attending Day-Care Centers (2005) (59)
- Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid) (2016) (59)
- Impact and Effectiveness of RotaTeq® Vaccine Based on 3 Years of Surveillance Following Introduction of a Rotavirus Immunization Program in Finland (2013) (59)
- Vaccine-derived Human-bovine Double Reassortant Rotavirus in Infants With Acute Gastroenteritis (2012) (58)
- Sildenafil for Severe Lymphatic Malformations (2012) (57)
- Clinical trials of live oral rotavirus vaccines: the Finnish experience. (1993) (57)
- Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. (1990) (57)
- Neonatal Septicaemia in Finland 1981–85 (1989) (57)
- Rotavirus vaccines against diarrhoeal disease (1997) (57)
- Primary Versus Secondary Failure After Varicella Vaccination: Implications for Interval Between 2 Doses (2013) (56)
- Clinical Trials of Rotavirus Vaccines in Europe (2006) (56)
- Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents (2015) (54)
- European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014. (2015) (53)
- Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea (1991) (53)
- Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1). (1987) (53)
- Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. (2012) (52)
- Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. (1998) (51)
- Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007 (2011) (51)
- A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults (2017) (50)
- Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in Europe: A Role for the Combined Vaccine (2007) (49)
- Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine (2015) (49)
- Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella (1985) (49)
- Options for the Prevention of Rotavirus Disease Other Than Vaccination (2008) (49)
- In Vitro Studies of Amphotericin B in Combination with the Imidazole Antifungal Compounds Clotrimazole and Miconazole (1978) (49)
- Glycine supplemented oral rehydration solutions for diarrhoea. (1986) (48)
- Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. (1998) (48)
- Neurologic Sequelae Following Interferon Therapy of Juvenile Laryngeal Papilloma (1988) (47)
- Review of rotavirus vaccine trials in Finland. (1996) (47)
- Detection of rotavirus RNA in cerebrospinal fluid in a case of rotavirus gastroenteritis with febrile seizures. (1996) (47)
- Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial. (2018) (46)
- Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents (2019) (46)
- A Comparative Trial of Rapid Oral and Intravenous Rehydration in Acute Diarrhoea (1987) (45)
- European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. (2008) (45)
- Efficacy and Immunogenicity of Live-attenuated Human Rotavirus Vaccine in Breast-fed and Formula-fed European Infants (2012) (45)
- Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo (2014) (44)
- Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants. (1985) (44)
- Oral rehydration, rapid feeding, and cholestyramine for treatment of acute diarrhea. (1985) (43)
- Human bocaviruses are commonly found in stools of hospitalized children without causal association to acute gastroenteritis (2014) (43)
- Rotavirus epidemiology 5–6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly (2017) (42)
- JC Virus Strains Indigenous to Northeastern Siberians and Canadian Inuits Are Unique But Evolutionally Related to Those Distributed Throughout Europe and Mediterranean Areas (2002) (42)
- INCREASED "TAKE" RATE OF ORAL ROTAVIRUS VACCINE IN INFANTS AFTER MILK FEEDING (1984) (42)
- Transmission of attenuated rubella vaccines to the human fetus. A preliminary report. (1969) (42)
- Immunogenicity and Safety of a Second Dose of Measles–Mumps–Rubella–Varicella Vaccine in Healthy Children Aged 5 to 6 Years (2007) (42)
- Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine (1975) (41)
- An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine Given Concomitantly With Diphtheria, Tetanus, Pertussis, and Poliomyelitis Vaccine in Healthy Adolescents 11 to 17 Years of Age (2009) (41)
- Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials. (2017) (41)
- Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus. (2012) (40)
- In vitro invasiveness of Yersinia enterocolitica isolated from children with diarrhea. (1978) (40)
- Purification of rubella virus particles. (1969) (40)
- Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease (2015) (40)
- Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers (2012) (40)
- Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination (2016) (40)
- Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen) (2011) (40)
- Rotavirus gastroenteritis in Finnish children in 2006–2008, at the introduction of rotavirus vaccination (2011) (40)
- Increase in bacteraemic pneumococcal infections in children (1995) (39)
- Enhancement of invasiveness of Yersinia enterocolitica and Escherichia coli in HEp-2 cells by centrifugation (1982) (38)
- Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study. (2011) (38)
- Yersiniosis in children. (1980) (38)
- Implementing Universal Varicella Vaccination in Europe: The Path Forward (2019) (38)
- Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents (2016) (38)
- Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months (2010) (37)
- Noroviruses in children seen in a hospital for acute gastroenteritis in Finland (2011) (37)
- Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine (2015) (37)
- Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture–Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of Age (2012) (37)
- Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children. (1984) (37)
- Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report (1987) (36)
- Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays. (2014) (35)
- Purification of norovirus-like particles (VLPs) by ion exchange chromatography. (2012) (34)
- Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. (2013) (34)
- An Open-Label, Randomized Study of a 9-Valent Human Papillomavirus Vaccine Given Concomitantly with Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccines to Healthy Adolescents 11–15 Years of Age (2015) (33)
- Clostridium Difficile in Young Children (1984) (33)
- Adherence and toxicity of Yersinia enterocolitica 0:3 and 0:9 containing virulence-associated plasmids for various cultured cells. (2009) (33)
- Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland (2016) (33)
- Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. (2007) (33)
- A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years (2012) (33)
- An update on the "Jennerian" and modified "Jennerian" approach to vaccination of infants and young children against rotavirus diarrhea. (1992) (32)
- Neonatal Administration of Rhesus Rotavirus Tetravalent Vaccine (2006) (32)
- Human bocavirus types 1, 2 and 3 in acute gastroenteritis of childhood (2012) (32)
- GENE POLYMORPHISM OF IFNG +874 T/A AND TLR4 +896 A/G AND RECURRENT INFECTIONS AND WHEEZING IN TODDLERS WITH HISTORY OF BRONCHIOLITIS (2009) (32)
- Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis. (2014) (32)
- Genotype Considerations for Virus-Like Particle-Based Bivalent Norovirus Vaccine Composition (2015) (32)
- Effect of rotavirus vaccine on Sapporo virus gastroenteritis in Finnish infants. (2001) (31)
- Simultaneous presence of human herpesvirus 6 and adenovirus infections in intestinal intussusception of young children (2012) (31)
- Rotavirus Antigenemia in Children is Associated With More Severe Clinical Manifestations of Acute Gastroenteritis (2014) (31)
- Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles (2013) (31)
- A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months. (2016) (31)
- Oral Rotavirus Vaccination in Breast‐ and Bottle‐Fed Infants Aged 6 to 12 Months (1986) (31)
- A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies. (2005) (29)
- Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland (2016) (29)
- Virus antibody levels in rheumatoid arthritis and systemic lupus erythematosus. (2009) (29)
- Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine (2015) (28)
- Report of the 5th European expert meeting on rotavirus vaccination (EEROVAC) (2018) (28)
- Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co‐delivered with norovirus VLPs (2017) (28)
- Detection of Vaccine-derived Rotavirus Strains in Nonimmunocompromised Children up to 3–6 Months After RotaTeq® Vaccination (2015) (28)
- Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age (2012) (28)
- Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials. (2019) (28)
- Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: A randomized study of a single dose vs. two different two-dose schedules (2013) (27)
- Safety and immunogenicity of oral tetravalent human-rhesus reassortant rotavirus vaccine in neonates. (1992) (27)
- QUANTITATIVE ASPECTS OF ROTAVIRUS EXCRETION IN CHILDHOOD DIARRHOEA (1981) (27)
- Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming. (2012) (27)
- Lymphoblast proliferation and humoral antibody response after rubella vaccination. (1973) (27)
- Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity. (1991) (27)
- Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. (2014) (27)
- EVALUATION IN YOUNG CHILDREN OF THE URABE AM 9 STRAIN OF LIVE ATTENUATED MUMPS VACCINE IN COMPARISON WITH THE JERYL LYNN STRAIN (1983) (26)
- Rapid and sensitive detection of norovirus antibodies in human serum with a biolayer interferometry biosensor (2015) (26)
- Evaluation of Live Attenuated Varicella Vaccine (Oka‐RIT Strain) and Combined Varicella and MMR Vaccination in 13–17‐Month‐Old Children (1991) (26)
- Norovirus-Specific Memory T Cell Responses in Adult Human Donors (2016) (26)
- Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles (2016) (26)
- Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants. (2011) (26)
- Randomised double blind study of hypotonic oral rehydration solution in diarrhoea (1997) (26)
- Take of rhesus‐human reassortant tetravalent rotavirus vaccine in breast‐fed infants (1993) (25)
- Results from a Randomized Clinical Trial of Coadministration of RotaTeq, a Pentavalent Rotavirus Vaccine, and NeisVac-C, a Meningococcal Serogroup C Conjugate Vaccine (2011) (25)
- Multiple consecutive norovirus infections in the first 2 years of life (2015) (25)
- Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults (2007) (25)
- Epidemiology of two human protoparvoviruses, bufavirus and tusavirus (2016) (24)
- ENTEROTOXIGENIC AND INVASIVE ESCHERICHIA COLI AS CAUSES OF CHILDHOOD DIARRHOEA IN FINLAND (1980) (24)
- Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (2015) (24)
- Faecal excretion of alpha-1-antitrypsin in acute diarrhoea. (1982) (23)
- Immune response in rubella infection. (1972) (23)
- Rubella during pregnancy as a cause of congenital hearing loss. (1973) (23)
- COMPARISON OF THE URABE AM 9‐SCHWARZ AND JERYL LYNN‐MORATEN COMBINATIONS OF MUMPS‐MEASLES VACCINES IN YOUNG CHILDREN (1983) (23)
- Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age. (2012) (23)
- Development and maturation of norovirus antibodies in childhood. (2016) (23)
- Acute tubulointerstitial nephritis in a patient with Mycoplasma pneumoniae infection. (1979) (23)
- Commonly circulating human coronaviruses do not have a significant role in the etiology of gastrointestinal infections in hospitalized children (2014) (22)
- Low Mumps Antibody Levels Induced by Mumps‐Measles‐Rubella Vaccinations in Type 1 Diabetic Children (1994) (22)
- Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children. (2015) (22)
- Development of T cell immunity to norovirus and rotavirus in children under five years of age (2019) (21)
- Induction of homologous and cross‐reactive GII.4‐specific blocking antibodies in children after GII.4 New Orleans norovirus infection (2015) (21)
- Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents. (2019) (21)
- Genetic diversity of JC virus in the Saami and the Finns: implications for their population history. (2005) (21)
- Middle ear fluid bacteriology of acute otitis media in neonates and very young infants. (1987) (21)
- Emerging data on the safety and efficacy of influenza vaccines in children. (2008) (20)
- A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months (2017) (20)
- A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3-, 5- and 11- to 12-month Schedule (2017) (20)
- Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study (2016) (20)
- Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial. (2021) (20)
- Trials of oral bovine and rhesus rotavirus vaccines in Finland: a historical account and present status. (1996) (20)
- Suppression of the response of lymphocytes to phytohemagglutinin in rubella. (1974) (19)
- Effect of rhesus rotavirus vaccine on enteric adenovirus--associated diarrhea in children. (1999) (19)
- Stable immobilisation of His-tagged proteins on BLI biosensor surface using cobalt (2017) (19)
- Association of high fever and short bacterial excretion after salmonellosis. (1992) (19)
- Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines (2015) (19)
- Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography (2012) (19)
- Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine (2015) (19)
- Congenital rubella: immune response of the neonate and diagnosis by demonstration of specific IgM antibodies. (1969) (19)
- Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16 (2017) (18)
- Norovirus vaccine: one step closer. (2015) (18)
- PERINATAL CAMPYLOBACTER FETUS SS JEJUNI ENTERITIS (1981) (18)
- Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study (2020) (18)
- Invasive pneumococcal infections in children (1995) (18)
- Norovirus gastroenteritis in young children receiving human rotavirus vaccine (2010) (17)
- Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq® (2014) (17)
- A Comparative Trial of Cholestyramine and Loperamide for acute Diarrhoea in Infants Treated as Outpatients (1985) (17)
- Prolonged efficacy of rhesus-human reassortant rotavirus vaccine. (1998) (17)
- Genetic diversity of G1P[8] rotavirus VP7 and VP8* antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq® vaccine. (2013) (17)
- Randomised double blind trial of hypotonic oral rehydration solutions with and without citrate. (1994) (16)
- Esophagitis and Findings of Long‐Term Esophageal pH Recording in Children with Repeated Lower Respiratory Tract Symptoms (1986) (16)
- Live baculovirus acts as a strong B and T cell adjuvant for monomeric and oligomeric protein antigens. (2017) (16)
- Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years of Age (2011) (16)
- Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013. (2014) (16)
- FAECAL LEUCOCYTES IN CAMPYLOBACTER‐ASSOCIATED DIARRHOEA IN INFANTS (1979) (16)
- Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein. (2016) (16)
- Report of the second European expert meeting on rotavirus vaccination. (2012) (16)
- Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays (1987) (16)
- Clinical trials of rotavirus vaccines. (2007) (15)
- Homologous and heterologous antibody responses to a one-year booster dose of an MF59®: Adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects (2012) (15)
- Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children. (1991) (15)
- Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial (2019) (15)
- The role of the sapovirus infection increased in gastroenteritis after national immunisation was introduced (2019) (14)
- Mucosal Antibodies Induced by Intranasal but Not Intramuscular Immunization Block Norovirus GII.4 Virus-Like Particle Receptor Binding. (2016) (14)
- Pathogenicity of 42-44 Mdal plasmid positive and negative Yersinia pseudotuberculosis I and Yersinia enterocolitica 0:8 and 0:9 studied in the guinea pig eye model (Serény test). (2009) (14)
- Epidemiologic background for the need of rotavirus vaccine in Finland. Preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults. (1983) (14)
- Rotavirus VP6 as an Adjuvant for Bivalent Norovirus Vaccine Produced in Nicotiana benthamiana (2019) (14)
- Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants. (1994) (13)
- Safety and Tolerability of Cold-Adapted Influenza Vaccine, Trivalent, in Infants Younger Than 6 Months of Age (2008) (13)
- Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant (2019) (13)
- Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine (2021) (13)
- TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines (2019) (13)
- Foreword: ESPID/ESPGHAN Evidence-Based Recommendations for Rotavirus Vaccination in Europe (2008) (13)
- Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine. (1994) (12)
- Rotaviruses in infants with diarrhea studied by viral RNA electrophoresis in Ankara, Turkey. (1987) (12)
- Antibody response in rubella reinfection. (1972) (12)
- Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype. (2013) (12)
- Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins (2016) (12)
- Progress in rotavirus vaccination. (1985) (12)
- Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. (2019) (12)
- Report of the Third European Expert Meeting on Rotavirus Vaccination: Progress in rotavirus universal mass vaccination in Europe. (2014) (11)
- Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children (1989) (11)
- Continuing rotavirus circulation in children and adults despite high coverage rotavirus vaccination in Finland. (2019) (11)
- Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST) (2014) (11)
- Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants. (2017) (11)
- Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures. (1975) (11)
- Spontaneous and inducible interleukin 1 production from peripheral blood monocytes in bacterial and viral infections in children. (1987) (11)
- Measles/mumps/rubella vaccine. (1988) (11)
- Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: A phase III randomized study. (2019) (11)
- Immunogenicity and safety of a low passage level bovine rotavirus candidate vaccine RIT 4256 in human adults and young infants. (1987) (10)
- Comparison of Intramuscular, Intranasal and Combined Administration of Norovirus Virus-Like Particle Subunit Vaccine Candidate for Induction of Protective Immune Responses in Mice (2015) (10)
- Norovirus-specific mucosal antibodies correlate to systemic antibodies and block norovirus virus-like particles binding to histo-blood group antigens. (2018) (10)
- Rotavirus vaccine studies in Europe (1999) (10)
- Report of the 'European Expert Meeting on Rotavirus Vaccination', Tampere, Finland, 19-20 May 2009. (2009) (10)
- Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo (2020) (10)
- Rotavirus vaccination for all children or subgroups only? Comment of the European Academy of Paediatrics (EAP) and the European Society for Paediatric Infectious Diseases (ESPID) recommendation group for rotavirus vaccination (2020) (10)
- Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus than Sequential Immunization (2019) (10)
- EVALUATION OF ELISA IN THE DIAGNOSIS OF YERSINIA ENTEROCOLITICA DIARRHOEA IN CHILDREN (1980) (10)
- Interleukin-1 production in bacterial meningitis. (1990) (10)
- Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study (2019) (9)
- Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential (2018) (9)
- Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset. (1989) (9)
- Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice (2018) (9)
- The role of scientific societies in the decision-making process to recommend new vaccines: the example of rotavirus in Europe (2008) (8)
- Cytokine determinations and rapid diagnosis of early onset neonatal septicaemia. (1999) (8)
- Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study (2018) (8)
- First international conference on infections in children in Arab countries. (1985) (8)
- Community‐based survey of paediatric diarrhoeal morbidity and home treatment practices in Finland (1998) (8)
- Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus. (1975) (8)
- Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes. (2018) (8)
- Rotavirus vaccination and infection induce VP6‐specific IgA responses (2017) (8)
- Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age (2020) (7)
- Antibody persistence to meningococcal serogroups A, C, W and Y in toddlers two years after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate (MenACWY-TT) vaccine as measured by bactericidal antibody assays using rabbit or human complement ☆ (2014) (7)
- Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for influenza infection in a vaccine efficacy trial. (2012) (7)
- Rotavirus vaccines: development and use for the prevention of diarrhoeal disease. (1999) (7)
- Safety and Immunogenicity of a Modified Process Hepatitis B Vaccine in Healthy Infants (2011) (7)
- Serotype-Specific Efficacy of the Pentavalent Rotavirus Vaccine against Hospitalizations and Emergency Department Visits up to Three Years: The Finnish Extension Study (2008) (7)
- Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera. (2018) (7)
- Clinical evaluation of radioimmunoassay of nasopharyngeal secretions and serology for diagnosis of viral infections in children hospitalized for respiratory infections (1982) (7)
- Concurrent administration of rhesus rotavirus tetravalent (RRV‐TV) vaccine with pentavalent diphtheria‐pertussis‐tetanus–Haemophilus influenzae b‐inactivated polio and hepatitis B vaccines (1999) (7)
- Clinical and immunological studies of rotavirus vaccines. (1988) (7)
- Clinical and laboratory features of Yersinia, Campylobacter and Salmonella infections in children. (1985) (7)
- A short report on highlights of world-wide development of RIX4414: an European experience. (2006) (6)
- Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1. (2019) (6)
- Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers. (2018) (6)
- Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study (2021) (6)
- Norovirus detection from sera of young children with acute norovirus gastroenteritis. (2016) (6)
- Glycinuria Following Administration of Glycine‐Supplemented Oral Rehydration Solution in Rotavirus Diarrhoea (1988) (6)
- Efficacy, Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine in Adults Aged 60 Years and Older: Results From the ZOE-50 and ZOE-70 Efficacy Studies (2016) (6)
- Effect of cholestyramine on acute diarrhoea in children receiving rapid oral rehydration and full feedings. (1986) (6)
- Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study. (2022) (6)
- A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEXAMETHASONE AND RACEMIC EPINEPHERINE IN THE TREATMENT OF GROUP (1988) (6)
- Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines (2019) (5)
- Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials (2015) (5)
- Raised acute-phase glycoprotein and IgM levels in cord serum. (1987) (5)
- Rotavirus (2008) (5)
- Incidence of rubella hemagglutination-inhibiting (HAI) antibody in female subjects in Helsinki. (1968) (5)
- Rotavirus infections and their prevention by vaccination. (1985) (5)
- Use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in a clinical trial in 3630 infants (2011) (5)
- Rotavirus vaccines (2008) (5)
- Neonatal rotavirus vaccination making headway. (2015) (4)
- Efficacy of Pentavalent Rotavirus Vaccine, RotaTeq™, against Hospitalizations and Emergency Department Visits through the Third Year: The Finnish Extension Study (2008) (4)
- Success of rotavirus vaccination in Africa: good news and remaining questions. (2016) (4)
- Human Protoparvovirus DNA and IgG in Children and Adults with and without Respiratory or Gastrointestinal Infections (2021) (4)
- Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months. (2021) (4)
- A two-year follow-up of rubella antibodies in a female population with special reference to reinfections. (1970) (4)
- Screening of rotavirus and adenovirus infections during prolonged hospitalization in a neonatal unit (2001) (4)
- Identification of a First Human Norovirus CD8+ T Cell Epitope Restricted to HLA-A*0201 Allele (2018) (4)
- Rubella antibodies in infants whose mothers had rubella during the second and third trimesters of pregnancy. (1971) (4)
- Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants. (2011) (4)
- [Prevention of congenital rubella]. (1974) (3)
- Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus (2005) (3)
- SUPPRESSED LYMPHOCYTE MITOGEN‐RESPONSIVENESS IN URINARY TRACT INFECTIONS OF CHILDREN AND ITS CORRELATION TO PYELONEPHRITIS (1979) (3)
- The synanthropy of blowflies (Diptera, Calli-phoridae) on the coast of the Arctic Ocean. (1966) (3)
- Efficacy of cholestyramine in acute infantile diarrhoea: placebo-controlled double-blind trial in hospitalized children and in outpatients. (1984) (3)
- Pediatric Vaccines and Vaccinations (2017) (3)
- Persistent rubella-specific IgM-antibody in the cerebrospinal fluid of a child with congenital rubella. (1980) (3)
- Pseudomembranous Colitis with Recurring Diarrhoea and Prolonged Persistence of Clostridium Difficile in A 10‐Year‐Old Girl (1984) (3)
- Ef fi cacy , Immunogenicity , and Safety of Two Doses of a Tetravalent Rotavirus Vaccine RRV-TV in Ghana With the First Dose Administered During the Neonatal Period (2013) (3)
- Small size rubella virus antigens and soluble immune complexes: Analysis by the platelet aggregation technique (2005) (3)
- Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses – results from two phase 2b randomized trials in adolescents (2021) (3)
- [Vaccination against measles, mumps and rubella--together or separately?]. (1979) (3)
- ANTIBODY PERSISTENCE 12 MONTHS FOLLOWING BOOSTER VACCINATION WITH A QUADRIVALENT MENINGOCOCCAL ACWY TETANUS TOXOID CONJUGATE VACCINE IN HEALTHY CHILDREN (2013) (2)
- Antibody levels to multiple viral antigens in systemic lupus erythematosus and some other connective tissue diseases. (1974) (2)
- Rotavirus Vaccine Development (1994) (2)
- A Randomized, Consistency Study Comparing Immunogenicity and Safety of 2 Vaccines Against Measles, Mumps and Rubella (MMR) Administered to Children 12–15 Months of Age (2016) (2)
- TWO-YEAR PROTECTION AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS VACCINE (1985) (2)
- Recurrent virus infections in identical twins with systemic lupus erythematosus. (1971) (2)
- Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. (2022) (2)
- [Viral vaccines in the national vaccination program--views of the near future]. (2013) (2)
- [Changing pattern of acute childhood diarrhea]. (1983) (2)
- Efficacy of an Inactivated Split-Virus Influenza Vaccine (2008) (1)
- Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins (2016) (1)
- IRITIS AND CONJUNCTIVITIS ASSOCIATED WITH CHICKENPOX (1981) (1)
- 987. Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study (2018) (1)
- Rotavirus Gastroenteritis in Europe. Proceedings of the Workshop on Rotavirus Surveillance in Europe. Geneva, 28-29 October 1996. (1999) (1)
- Rotavirus Vaccines and Vaccination (2016) (1)
- Higher proportion of responders with hepatitis B antibody levels ≥ 100 miu/ml with the trivalent HepB vaccine, Sci-B-Vac, compared to Engerix-B: results from the phase 3 double-blind, randomized study comparing immunogenicity and safety (PROTECT) (2020) (1)
- CO-ADMINISTRATION OF PENTAVALENT ROTAVIRUS VACCINE, ROTATEQ®, WITH MENINGOCOCCAL GROUP C CONJUGATE VACCINE: IMMUNOGENICITY AND SAFETY (2008) (1)
- Comment on the contribution by Weycker et al., "Cost of routine immunization of young children against rotavirus infection with Rotarix ® versus RotaTeq ®". (2010) (1)
- 1082Safety, Tolerability, and Immunogenicity of an Investigational Meningococcal Serogroup B Bivalent rLP2086 Vaccine in Healthy Adolescents Aged 11 to 18 Years in Three Phase 2, Randomized, Controlled Studies (2014) (1)
- [Role of bacteria and viruses in the etiology of acute gastroenteritis in children]. (1978) (1)
- [The health of the world's children]. (1985) (1)
- Trimeric S protein COVID-19 vaccine needs to find its place (2022) (1)
- Intussusception after human rotavirus vaccine. (2013) (1)
- Case 10-2012: A Boy with Epigastric Pain and a Mediastinal Mass (2012) (1)
- The platelet aggregation test (PA) as an immunological method in virology. (1970) (1)
- Health of the world's children. (1979) (1)
- From rubella to rotavirus, and beyond (2015) (1)
- Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies. (2020) (1)
- Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children. (2020) (1)
- Study of the lymphocytein vitro response to rubella antigen and phytohemagglutinin by a whole blood method (2005) (1)
- HIGH AND SUSTAINED EFFICACY OF ROTATEQ® TO REDUCE ANY SEVERITY AND SEVERE ROTAVIRUS DISEASE IN EUROPE (2008) (1)
- 12. LONG TERM PROTECTION AGAINST SEVERE ROTAVIRUS DIARRHOEA BY A SINGLE DOSE OF BOVINE ROTAVIRUS VACCINE STRAIN RIT 4237 GIVEN IN THE NEONATAL PERIOD. (1988) (0)
- Rotavirus vaccine: Current status (1987) (0)
- [Antiviral agents and the practicing physician]. (2000) (0)
- Viral infections associated with acute urinary tract infections in children (1979) (0)
- Rubella: aMethodforRapidDiagnosis ofaRecentInfection by Demonstration oftheIgMAntibodies (1968) (0)
- Interleukin-1 induction by Yersinia enterocolitica. (1987) (0)
- Randomised double blind trial ofhypotonic oral rehydration solutions withandwithout citrate (1994) (0)
- Current status of diagnostic procedures for intrauterine rubella and cytomegalovirus infections. (1983) (0)
- INCIDENCE, ETIOLOGY, CLINICAL SIGNIFICANCE AND RISK FACTORS OF ACUTE DIARRHOEA: A PROSPECTIVE COMMUNITYBASED STUDY (1989) (0)
- INVASIVE PNEUMOCOCCAL INFECTIONS IN CHILDREN. AUTHORS' REPLY (1995) (0)
- [Does vaccination prevent Rotavirus gastroenteritis?]. (1994) (0)
- Live Attenuated Influenza Vaccine in Infants 6 Through 23 Months of Age (2009) (0)
- [New medication for herpesvirus infections]. (1995) (0)
- In A New Study Rotarix TM Offers 96% Protection Against Severe Rotavirus Gastroenteritis And Prevents 100% Of Rotavirus-associated Hospitalisations (2008) (0)
- MF59 ® Adjuvanted Influenza Vaccine Confers Broader Immunogenicity in Children Aged 6 to <36 Months, Compared with an Unadjuvanted Split Vaccine: Preliminary Results (2008) (0)
- EFFECT OF BREAST-FEEDING ON THE TAKE OF RIT 4237 ORAL ROTAVIRUS VACCINE (1985) (0)
- Effectiveness of the 10-Valent Pneumococcal NTHi Protein D Conjugate Vaccine against AOM (2012) (0)
- [A modern view of rubella]. (1968) (0)
- [Neonatal sepsis in Finland over one decade]. (1989) (0)
- Suppression of lymphocyte PHA-responsiveness after rubella vaccination with Cendehill and RA 27/3 strains. (1980) (0)
- PVII-4 Human bocavirus and acute gastroenteritis in children (2009) (0)
- Vaccine Reports (0)
- Caring for the next generation : developments in pediatric vaccination, Sorrento, Italy, 6 and 7 April 1995 (1996) (0)
- Efficacy, Immunogenicity and Safety of adjuvanted Herpes Zoster-Virus Subunit Vaccine Candidates in Adults from 60 Years and older : Results from the Efficacy Studies ZOE-50 and ZOE-70 (2018) (0)
- Primary versus secondary failure following varicella vaccination: implications for interval between two doses-Literature review (2010) (0)
- 8. Higher hepatitis B antibody titres induced in all adults vaccinated with a tri-antigenic hepatitis B (HBV) vaccine, compared to a mono-antigenic HBV vaccine: results from two pivotal phase 3 double-blind, randomized studies (PROTECT and CONSTANT) (2020) (0)
- Evaluation of clinical case definitions for respiratory syncytial virus lower respiratory tract infection in young children. (2023) (0)
- [Mumps vaccination and morbidity in the Finnish Army 1967-70]. (1971) (0)
- Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings (2022) (0)
- LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT) (2019) (0)
- Immunogenicity of MenB-FHbp (Bivalent rLP2086), a Meningococcal Serogroup B Vaccine, in US Adolescents: Results From a Phase 3 Trial (2016) (0)
- [Effect of live mumps vaccine alone and in combination with measles vaccine in infants]. (1982) (0)
- 195-LB: Lower Nonresponse Rates to 3-Antigen HBV Vaccine among Adults with Diabetes, Age 45 and Over, or Obesity Compared with a Single-Antigen HBV Vaccine: PROTECT Study (2021) (0)
- Paediatric Vaccination Trials (2010) (0)
- [Viral infections in pregnancy and their effects on the fetus]. (1978) (0)
- Peer Review #1 of "Reconstructing the transmission dynamics of varicella in Japan: an elevation of age at infection (v0.1)" (2022) (0)
- High HBsAb titers consistent across 3 lots of the trivalent HepB vaccine, Sci-B-Vac: Results from the second pivotal phase 3 double-blind, randomized controlled trial designed to assess the lot-to-lot consistency of Sci-B-Vac in adults (CONSTANT) (2020) (0)
- RIX4414 ( Rotarix ™) is Highly Effective against Severe RVGE Caused by Specific Rotavirus Types during the First Two Years of Life. (2007) (0)
- Peer Review #1 of "Reconstructing the transmission dynamics of varicella in Japan: an elevation of age at infection (v0.2)" (2022) (0)
- Session 5 : Viral Infection in Children 8. Acute Gastroenteritis in Finnish Children : Etiology and impact of Rotavirus Vaccination (2000) (0)
- [Varicella vaccinations for everybody or for selected groups?]. (2002) (0)
- Norovirus GII.17 virus-like particles bind to different HBGAs and cross-react with genogroup II-specific mouse sera (2018) (0)
- 1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine (2020) (0)
- Maternal Immunization (2021) (0)
- [Not Available]. (2006) (0)
- DETECTION OF VACCINE-DERIVED ROTAVIRUS STRAINS IN NON-IMMUNOCOMPROMISED CHILDREN UP TO 3-6 MONTHS AFTER VACCINATION (2015) (0)
- [Vaccines today and tomorrow. Rotavirus vaccine to prevent infant mortality in developing countries]. (1989) (0)
- Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa (2017) (0)
- CELL-MEDIATED IMMUNITY IN RUBELLA ASSAYED BY A CYTOTOXICITY TEST AND BY LYMPHOCYTE STIMULATION (1974) (0)
- Progress on enteric vaccines (2003) (0)
- Rotavirus vaccines for prevention of acute gastroenteritis in young infants (1992) (0)
- [Varicella vaccination]. (1993) (0)
- PVII-6 Prevalence of norovirus GII-4 antibodies in Finnish children (2009) (0)
- Estonian Higher Education Accreditation Centre (2009) (0)
- [Rubella as a complication of pregnancy]. (1968) (0)
- [Infectious complications in childhood leukemia]. (1983) (0)
- RT-PCR STUDIES SHOW THAT ROTAVIRUSES AND HUMAN CALICIVIRUSES ARE THE TWO LEADING CAUSES OF ACUTE GASTROENTERITIS IN YOUNG CHILDREN (1999) (0)
- Rubella serology and abortions in Finland. (1972) (0)
- [Intrauterine infections; a cause of central nervous system disorders]. (1979) (0)
- Norovirus Vaccines in Pipeline Development (2021) (0)
- Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials q (2019) (0)
- 1506. Burden of Respiratory Syncytial Virus (RSV) and Other Lower Respiratory Tract Viral Infections During the First Two Years of Life: a Prospective Study (2020) (0)
- Reactogenicity of an adjuvanted herpes zoster subunit vaccine in older adults: results of the phase 3 ZOE-50 trial (2015) (0)
- Measles–Mumps–Rubella Vaccine (2021) (0)
- 6 LACTOBACILLUS REUTERI EFFECTIVELY COLONISES Gl TRACT AND SHORTENS ACUTE DIARRHOEA IN CHILDREN (1996) (0)
- Rotavirus Vaccination Programme is not Only about Costs (2013) (0)
- PVII-5 Significance of norovirus genotype GII.4 in endemic acute gastroenteritis of infants and children in 1993–2007 (2009) (0)
- citrate . oral rehydration solutions with and without Randomised double blind trial of hypotonic (2004) (0)
- Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography (2012) (0)
- POLIOVIRUS VACCINES (1961) (0)
- CLINICAL TRIALS OF RHESUS ROTAVIRUS (REV-1) VACCINE IN YOUNG INFANTS (1986) (0)
- [Not Available]. (2007) (0)
- [Viral infections during pregnancy]. (1971) (0)
- Long term persistence of anti-HBs antibodies after vaccination with a 3-antigen HBV vaccine compared to a single-antigen HBV vaccine (2022) (0)
- Evaluation of attenuated rotavirus (RV) vaccines for the prevention of severe diarrhea in infants and young children (1992) (0)
- Standardised case definitions for adverse events following immunisation – Authors'reply (2013) (0)
- Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine (2015) (0)
- Viral Gastroenteritis: Sickness Symptoms and Behavioral Responses (2023) (0)
- GG in acute rotavirus diarrhoea . Viable versus inactivated lactobacillus strain (2006) (0)
- Cross subclade immunity after one-year booster immunization with MF59®-adjuvanted A/H5N1 influenza vaccine in 6 month to 17 year-old children (2012) (0)
- Development of T cell immunity to norovirus and rotavirus in children under five years of age (2019) (0)
- Rotavirus vaccine (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Timo Vesikari?
Timo Vesikari is affiliated with the following schools:
